Previous close | 146.82 |
Open | 146.70 |
Bid | 145.88 x 1100 |
Ask | 146.14 x 800 |
Day's range | 145.95 - 147.18 |
52-week range | 143.13 - 175.97 |
Volume | |
Avg. volume | 7,640,096 |
Market cap | 352.165B |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | 19.70 |
EPS (TTM) | 7.42 |
Earnings date | 17 Jul 2024 |
Forward dividend & yield | 4.96 (3.39%) |
Ex-dividend date | 20 May 2024 |
1y target est | 173.75 |
AbbVie's (ABBV) first-quarter earnings and sales beat estimates. Management hikes the EPS guidance on the back of encouraging Skyrizi product sales.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
Five stocks to focus with recent dividend hike are: JNJ, TRV, SON, KBH, SPFI.